Article PDF
Avoid common mistakes on your manuscript.
References
Azarnoff, D.L.: Drug interactions: clinical significance. Clin. Pharmacol. Ther.16, 986–988 (1974)
Sellers, E.M., Koch-Weser, J.: Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs. Ann. N. Y. Acad. Sci.179, 213–225 (1971)
Koch-Weser, J., Sellers, E.M.: Drug interactions with coumarin anticoagulants. New Engl. J. Med.285, 487–498, 547–558 (1971)
Koch-Weser, J.: Detection of drug interactions in man. In: Pharmacokinetics, Drug Metabolism and Drug Interactions (ed. F.G. McMahon, T.E. Gaffney, J. Koch-Weser, J.G. Wagner), pp. 169–182. Mount Kisco, N.Y.: Futura Publishing Co. 1974
Weiner, M.: The clinical significance of drug interactions. In: Pharmacokinetics, Drug Metabolism and Drug Interactions (ed. F.G. McMahon, T.E. Gaffney, J. Koch-Weser, J.G. Wagner), pp. 183–189. Mount Kisco, N.Y.: Futura Publishing Co. 1974
Stewart, R.B., Cluff, L.E.: Methods of study of drug interactions. In: Clinical Effects of Interactions between Drugs (ed. L.E. Cluff, J.C. Petrie) pp. 9–38. Amsterdam: Excerpta Medica 1974
Schary, W.L., Lewis, R.J., Rowland, M.: Warfarin-phenylbutazone interaction in man: a long term multiple dose study. Res. Commun. Chem. Pathol. Pharmacol.10, 663–672 (1975)
Greenblatt, D.J., Koch-Weser, J.: Clinical pharmacokinetics. New Engl. J. Med.293, 702–705, 964–970 (1975)
Koch-Weser, J., Sellers, E.M.: Binding of drugs to serum albumin. New Engl. J. Med.294, 311–316, 526–531 (1976)
Hunninghake, D.B., Azarnoff, D.L.: Drug interactions with warfarin. Arch. Intern. Med.121, 349–352 (1968)
Udall, J.A.: Warfarin therapy not influenced by meprobamate. A controlled study in nine men. Curr. Ther. Res.12, 724–728 (1970)
Gould, L., Michael, A., Fisch, S., Gomprecht, R.F.: Prothrombin levels maintained with meprobamate and warfarin. J. Amer. Med. Ass.220, 1460–1462 (1972)
Cucinell, S.A., Odessky, L., Weiss, M., Dayton, P.G.: The effect of chloral hydrate on bishydroxycoumarin metabolism. J. Amer. Med. Ass.197, 366–368 (1966)
Koch-Weser, J.: Drug interactions during oral anticoagulant therapy. In: Drugs and Hematologic Reactions (ed. N.V. Dimitrov, J.H. Nodine), pp. 297–310. New York: Grune and Straoton 1974
Sellers, E.M., Koch-Weser, J.: Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate. New Engl. J. Med.283, 827–831 (1970)
Koch-Weser, J., Sellers, E.M.: Chloral hydrate and warfarin therapy. Ann. Intern. Med.75, 141–142 (1971)
Sellers, E.M., Lang, M., Koch-Weser, J., Colman, R.W.: Enhancement of warfarin-induced hypoprothrombinemia by triclofos. Clin. Pharmacol. Ther.13, 911–915 (1972)
Boston Collaborative Drug Surveillance Program: Interaction between chloral hydrate and warfarin. New Engl. J. Med.286, 53–55 (1972)
Gander, D.R.: Treatment of depressive illnesses with combined antidepressants. Lancet1965 II, 107–109
Schuckit, M., Robins, E., Feighner, J.: Tricyclic antidepressants and monoamine oxidase inhibitors. Arch. Gen. Psychiatry24, 509–515 (1971)
Winston, F.: Combined antidepressant therapy. Brit. J. Psychiatry118, 301–304 (1971)
Sethna, E.R.: A study of refractory cases of depressive illnesses and their responses to combined antidepressant treatment. Brit. J. Psychiatry124, 265–272 (1974)
Spiker, D.G., Pugh, D.D.: Combining tricyclic and monoamine oxidase inhibitor antidepressants. Arch. Gen. Psychiatry33, 828–834 (1976)
Koch-Weser, J.: Clinical detection of drug interactions. Drug Information J.6, 42–47 (1972)
Koch-Weser, J.: Bioavailability of drugs. New Engl. J. Med.291, 233–237, 503–506 (1974)
Smith, S.E., Rawlins, M.: Variability in Human Drug Response. London: Butterworth 1973
Cluff, L.E., Petrie, J.C. (ed.): Clinical Effects of Interaction between Drugs. Amsterdam: Excerpta Medica 1974
Cluff, L.E., Caranasos, G.J., Stewart, R.B.: Drug interactions. In: Clinical Problems with Drugs (ed. Cluff, L.E., Caranasos, G.J., Stewart, R.B.), pp. 261–271. Philadelphia: W.B. Saunders Co. 1975
Cohen, S.N., Armstrong, M.F.: Drug Interactions: A Handbook for Clinical Use. Baltimore: Williams and Wilkins (1974)
Hansten, P.D.: Drug Interactions: Clinical Significance of Drug-Drug Interactions and Drug Effects on Clinical Laboratory Results. Philadelphia: Lea and Febiger 1975
Koch-Weser, J.: Drug interactions in cardiovascular therapy. Amer. Heart J.90, 93–116 (1975)
Prescott, L.F.: Clinically Important Drug Interactions. In: Drug Treatment: Principles and Practice of Clinical Pharmacology and Therapeutics (ed. G.S. Avery) pp. 193–213. Sidney: Adis Press 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koch-Weser, J., Greenblatt, D.J. Drug interactions in clinical perspective. Eur J Clin Pharmacol 11, 405–408 (1977). https://doi.org/10.1007/BF00562929
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00562929